Here are five notes.
1. The company expects the transaction to close in the second quarter of 2018.
2. Financial terms were not disclosed.
3. DePuy Synthes plans to expand MED’s surgical impactor technology for various orthopedic surgery procedures.
4. The battery-powered ME1000 automates bone preparation, implant assembly and positioning in total hip arthroplasty. Designed to replace handheld mallets, the device can be used with several surgical approaches, including the anterior approach.
5. DePuy Synthes recently entered into an exclusive marketing agreement with JointPoint to co-market a system for digital templating, implant selection and implant positioning during hip replacement procedures. JointPoint is compatible with the ME1000.
More articles on supply chain:
EpiPens in short supply, FDA warns — 4 insights
President Trump vows to ‘bring soaring drug prices back down to earth’ — 6 takeaways
5 things to know about McKesson Corp.
